Insider Transactions in Q2 2022 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2022
|
Paul J Mellett Chief Fin. & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,480
+5.35%
|
$38,280
$11.77 P/Share
|
|
Apr 04
2022
|
Nathalie Adda Sr. VP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
32,785
-14.66%
|
$2,360,520
$72.08 P/Share
|
|
Apr 04
2022
|
Nathalie Adda Sr. VP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,785
+16.35%
|
$1,672,035
$51.81 P/Share
|
|
Apr 01
2022
|
Nathalie Adda Sr. VP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,559
-32.21%
|
$3,589,689
$71.04 P/Share
|
|
Apr 01
2022
|
Nathalie Adda Sr. VP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,559
+18.29%
|
$1,820,124
$36.65 P/Share
|